CDB-4124

	WikiDoc Resources for CDB-4124
Articles
Most recent articles on CDB-4124 Most cited articles on CDB-4124 Review articles on CDB-4124 Articles on CDB-4124 in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on CDB-4124 Images of CDB-4124 Photos of CDB-4124 Podcasts & MP3s on CDB-4124 Videos on CDB-4124
Evidence Based Medicine
Cochrane Collaboration on CDB-4124 Bandolier on CDB-4124 TRIP on CDB-4124
Clinical Trials
Ongoing Trials on CDB-4124 at Clinical Trials.gov Trial results on CDB-4124 Clinical Trials on CDB-4124 at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on CDB-4124 NICE Guidance on CDB-4124 NHS PRODIGY Guidance FDA on CDB-4124 CDC on CDB-4124
Books
Books on CDB-4124
News
CDB-4124 in the news Be alerted to news on CDB-4124 News trends on CDB-4124
Commentary
Blogs on CDB-4124
Definitions
Definitions of CDB-4124
Patient Resources / Community
Patient resources on CDB-4124 Discussion groups on CDB-4124 Patient Handouts on CDB-4124 Directions to Hospitals Treating CDB-4124 Risk calculators and risk factors for CDB-4124
Healthcare Provider Resources
Symptoms of CDB-4124 Causes & Risk Factors for CDB-4124 Diagnostic studies for CDB-4124 Treatment of CDB-4124
Continuing Medical Education (CME)
CME Programs on CDB-4124
International
CDB-4124 en Espanol CDB-4124 en Francais
Business
CDB-4124 in the Marketplace Patents on CDB-4124
Experimental / Informatics
List of terms related to CDB-4124

CDB-4124 (Proellex™, Progenta™) is a selective progesterone receptor modulator.^[1]

References

↑ Attardi BJ, Burgenson J, Hild SA, Reel JR (2004). "In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone". J Steroid Biochem Mol Biol. 88 (3): 277–88. doi:10.1016/j.jsbmb.2003.12.004. PMID 15120421.